BAXTER INTERNATIONAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.13 USD | -0.25% |
|
+1.67% | +3.80% |
| 04-23 | Edwards Lifesciences Corporation: The story continues |  |
| 04-15 | Exact Sciences Names Aaron Bloomer CFO | MT |
Chart calendar Baxter International Inc.
ec12829323eec.bHRcMTLFMfo4Cl5k5dWIHp43jJh2bsp1fpSDA9Mnx-A.DTAOAnG8abtLaBoo0Iq7LNYPuvkhXb0BNfzmU-AXt5MKJBQHYYJro1FQLQ~79999385f519238ac769bbaf8f1bc913
Upcoming events on Baxter International Inc.
Past events on Baxter International Inc.
| 04/03/2024 21:00 | Raymond James Institutional Investors Conference |
| 28/02/2024 | Ex-dividend day |
| 08/02/2024 13:30 | Q4 2023 Earnings Call |
| 08/02/2024 12:15 | Q4 2023 Earnings Release |
| 08/01/2024 18:30 | JPMorgan Healthcare Conference |
| 29/11/2023 | Ex-dividend day |
| 02/11/2023 12:30 | Q3 2023 Earnings Call |
| 02/11/2023 11:15 | Q3 2023 Earnings Release |
| 25/10/2023 | American Academy of Family Physicians Family Medicine Experience Conference |
| 19/10/2023 | American Academy of Pediatrics National Conference |
| 13/09/2023 14:30 | Morgan Stanley Global Healthcare Conference |
| 07/09/2023 13:45 | Wells Fargo Healthcare Conference |
| 30/08/2023 | Ex-dividend day |
| 27/07/2023 13:30 | Q2 2023 Earnings Call |
| 27/07/2023 12:15 | Q2 2023 Earnings Release |
| 08/06/2023 15:00 | Jefferies Global Healthcare Conference |
| 31/05/2023 | Ex-dividend day |
| 09/05/2023 18:00 | Bank of America Healthcare Conference |
| 02/05/2023 15:00 | Annual General Meeting |
| 27/04/2023 13:30 | Q1 2023 Earnings Call |
Past dividends on Baxter International Inc.
| 28/02/2024 | Quarterly 0.29 USD |
| 29/11/2023 | Quarterly 0.29 USD |
| 30/08/2023 | Quarterly 0.29 USD |
| 31/05/2023 | Quarterly 0.29 USD |
| 22/02/2023 | Quarterly 0.29 USD |
| 30/11/2022 | Quarterly 0.29 USD |
| 31/08/2022 | Quarterly 0.29 USD |
| 01/06/2022 | Quarterly 0.29 USD |
| 23/02/2022 | Quarterly 0.28 USD |
| 01/12/2021 | Quarterly 0.28 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11 362 11 324 0.33% | 11 673 11 582 0.79% | 12 784 12 623 1.28% | 15 113 15 001 0.74% | 14 813 14 748 0.44% | 15 107 |
|
EBITDA Million USD | Released Forecast Spread | 2 726 2 716 0.37% | 2 698 2 683 0.57% | 3 003 3 019 -0.53% | 3 233 3 426 -5.63% | 2 734 2 798 -2.29% | 2 903 |
|
EBIT Million USD | Released Forecast Spread | 2 120 2 082 1.83% | 2 097 2 045 2.52% | 2 400 2 369 1.32% | 2 583 2 611 -1.05% | 2 123 2 133 -0.48% | 2 250 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 970 1 328 -26.95% | 1 292 1 410 -8.35% | 1 477 2 029 -27.21% | -2 353 2 262 -204.03% | -103 1 679 -106.14% | 1 401 |
|
Net income Million USD | Released Forecast Spread | 1 001 1 677 -40.3% | 1 102 1 344 -18.01% | 1 284 1 584 -18.95% | -2 433 -2 086 -16.64% | 2 656 2 831 -6.18% | 747 |
|
EPS USD | Released Forecast Spread | 1,93 2,98 -35.16% | 2,13 2,62 -18.57% | 2,53 3,12 -19.01% | -4,83 -1,37 -252.23% | 5,25 3,04 72.7% | 1,88 |
| Announcement Date | 17/03/20 | 04/02/21 | 17/02/22 | 09/02/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 514 3 346 5.03% | 3 707 3 682 0.69% | 3 746 3 881 -3.49% | 3 773 3 769 0.12% | 3 887 3 766 3.2% | 3 649 3 601 1.32% | 3 707 3 786 -2.08% | 3 708 3 697 0.31% | 3 885 3 806 2.08% | 3 551 | 3 768 | 3 789 | 3 991 | 3 702 |
|
EBITDA Million USD | Released Forecast Spread | 821 844 -2.69% | 829 785 5.56% | 1 147 815 40.74% | 815 864 -5.64% | 822 885 -7.08% | 660 718 -8.03% | 798 779 2.38% | 714 726 -1.65% | 783 800 -2.11% | 649 | 719 | 736 | 828 | |
|
EBIT Million USD | Released Forecast Spread | 714 680 5.07% | 666 601 10.82% | 605 645 -6.19% | 649 620 4.61% | 663 685 -3.16% | 503 458 9.79% | 489 540 -9.42% | 565 552 2.34% | 630 630 -0.02% | 481 | 529 | 584 | 653 | 541 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 283 629 -54.98% | 94,0 505 -81.38% | 295 546 -45.93% | -2 966 516 -674.94% | 224 570 -60.67% | 70,0 318 -77.98% | -183 398 -145.94% | -172 423 -140.67% | 238 568 -58.08% | 411 | 438 | 495 | 568 | |
|
Net income Million USD | Released Forecast Spread | 238 477 -50.07% | 71,0 341 -79.18% | 252 375 -32.77% | -2 937 354 -929.31% | 181 411 -55.98% | 44,0 87,0 -49.43% | 335 151 122% | 2 508 | 167 | 225 | 232 | 264 | ||
|
EPS USD | Released Forecast Spread | 0,47 0,89 -47.19% | 0,14 0,57 -75.44% | 0,50 0,55 -9.64% | -5,83 0,59 -1092.34% | 0,36 0,73 -50.68% | 0,09 0,19 -51.79% | 0,66 0,20 230% | 4,93 -0,16 3181.25% | 0,48 0,45 6.67% | 0,33 | 0,44 | 0,45 | 0,52 | |
| Announcement Date | 17/02/22 | 28/04/22 | 28/07/22 | 27/10/22 | 09/02/23 | 27/04/23 | 27/07/23 | 02/11/23 | 08/02/24 | - | - | - | - | - |
More events
Past sector events for Baxter International Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BAX Stock
- Calendar Baxter International Inc.
